Financials

News Ideas Discussions Technicals Seasonals

HEMO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01(POST REORG) operating, investing, and financing activities

HEMO free cash flow for H2 24 is -1.8 M GBP. For 2024, HEMO free cash flow was -4.13 M GBP and operating cash flow was -4.12 M GBP.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: GBP

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—